Assignee
DEPOMED INC
US·32 granted patents·24 pending applications·3,135 citations·filing 1995–2017
Top patents by PatentIndex Score
56 records- 0199US6488962B1Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage formsDEPOMED INC·Filed 2000·Granted Dec 3, 2002·442 cites·27 claims
- 0298US7731989B2Gastric retained gabapentin dosage formDEPOMED INC·Filed 2008·Granted Jun 8, 2010·22 cites·20 claims
- 0398US6635280B2Extending the duration of drug release within the stomach during the fed modeDEPOMED INC·Filed 2001·Granted Oct 21, 2003·282 cites·70 claims
- 0498US6340475B2Extending the duration of drug release within the stomach during the fed modeDEPOMED INC·Filed 1999·Granted Jan 22, 2002·519 cites·89 claims
- 0598US5972389AGastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matterDEPOMED INC·Filed 1996·Granted Oct 26, 1999·456 cites·33 claims
- 0698US5582837AAlkyl-substituted cellulose-based sustained-release oral drug dosage formsDEPOMED INC·Filed 1995·Granted Dec 10, 1996·314 cites·34 claims
- 0797US6682759B2Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugsDEPOMED INC·Filed 2002·Granted Jan 27, 2004·203 cites·14 claims
- 0896US7976870B2Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tractDEPOMED INC·Filed 2004·Granted Jul 12, 2011·82 cites·23 claims
- 0996US7438927B2Methods of treatment using a gastric retained gabapentin dosageDEPOMED INC·Filed 2003·Granted Oct 21, 2008·56 cites·67 claims
- 1095US9566258B2Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disordersDEPOMED INC·Filed 2015·Granted Feb 14, 2017·17 cites·15 claims
- 1195US8945619B2Shell-and-core dosage form approaching zero-order drug releaseDEPOMED INC·Filed 2012·Granted Feb 3, 2015·28 cites·23 claims
- 1295US8372432B2Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesicDEPOMED INC·Filed 2009·Granted Feb 12, 2013·20 cites·27 claims
- 1395US8043630B2Shell-and-core dosage form approaching zero-order drug releaseDEPOMED INC·Filed 2010·Granted Oct 25, 2011·26 cites·20 claims
- 1494US8999388B2Dual drug dosage forms with improved separation of drugsDEPOMED INC·Filed 2014·Granted Apr 7, 2015·11 cites·17 claims
- 1594US8377453B2Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesicDEPOMED INC·Filed 2009·Granted Feb 19, 2013·47 cites·29 claims
- 1694US6723340B2Optimal polymer mixtures for gastric retentive tabletsDEPOMED INC·Filed 2001·Granted Apr 20, 2004·299 cites·19 claims
- 1793US9572780B2Dual drug dosage forms with improved separation of drugsDEPOMED INC·Filed 2015·Granted Feb 21, 2017·12 cites·18 claims
- 1892US9937142B2Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disordersDEPOMED INC·Filed 2017·Granted Apr 10, 2018·9 cites·15 claims
- 1991US7405238B2Pharmacological inducement of the fed mode for enhanced drug administration to the stomachDEPOMED INC·Filed 2002·Granted Jul 29, 2008·36 cites·5 claims
- 2090US9597338B2Shell-and-core dosage form approaching zero-order drug releaseDEPOMED INC·Filed 2014·Granted Mar 21, 2017·9 cites·24 claims
- 2190US9301934B2Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tractDEPOMED INC·Filed 2015·Granted Apr 5, 2016·9 cites·6 claims
- 2290US7736667B2Shell-and-core dosage form approaching zero-order drug releaseDEPOMED INC·Filed 2002·Granted Jun 15, 2010·26 cites·55 claims
- 2389US8802157B2Methods of treatment using a gastric retained gabapentin dosage formDEPOMED INC·Filed 2013·Granted Aug 12, 2014·7 cites·13 claims
- 2489US8592481B2Gastric retentive gabapentin dosage forms and methods for using sameDEPOMED INC·Filed 2012·Granted Nov 26, 2013·8 cites·12 claims
- 2589US7612112B2Methods of treatment using a gastric retained gabapentin dosageDEPOMED INC·Filed 2004·Granted Nov 3, 2009·20 cites·18 claims
- 2687US7413751B2Methods of treatment using a gastric retained losartan dosageDEPOMED INC·Filed 2002·Granted Aug 19, 2008·31 cites·20 claims
- 2787US6451808B1Inhibition of emetic effect of metformin with 5-HT3 receptor antagonistsDEPOMED INC·Filed 2000·Granted Sep 17, 2002·142 cites·11 claims
- 2876US8252332B2Gastric retained gabapentin dosage formDEPOMED INC·Filed 2010·Granted Aug 28, 2012·1 cites·24 claims
- 2974US2015157558A1Methods of treatment using a gastric retained gabapentin dosage formDEPOMED INC·Filed 2014·Application pending·0 cites
- 3072US9801816B2Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tractDEPOMED INC·Filed 2016·Granted Oct 31, 2017·1 cites·15 claims
- 3172US8580303B2Gastric retained gabapentin dosage formDEPOMED INC·Filed 2013·Granted Nov 12, 2013·0 cites·16 claims
- 3271US9561200B2Method of treating post-surgical acute painDEPOMED INC·Filed 2013·Granted Feb 7, 2017·0 cites·16 claims
- 3370US2009176882A1Gastric retentive gabapentin dosage forms and methods for using sameDEPOMED INC·Filed 2008·Application pending·0 cites
- 3470US2014186440A1Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesicDEPOMED INC·Filed 2014·Application pending·0 cites
- 3567US2016263044A1Methods of treatment using a gastric retained gabapentin dosage formDEPOMED INC·Filed 2016·Application pending·0 cites
- 3667US2017128400A1Method of treating post-surgical acute painDEPOMED INC·Filed 2017·Application pending·0 cites
- 3766US2014072623A1Gastric retained gabapentin dosage formDEPOMED INC·Filed 2013·Application pending·0 cites
- 3866US2009028941A1Pulsatile gastric retentive dosage formsDEPOMED INC·Filed 2008·Application pending·0 cites
- 3966US2017202817A1Dual drug dosage forms with improved separation of drugsDEPOMED INC·Filed 2017·Application pending·0 cites
- 4063US2014135395A1Gastric retentive gabapentin dosage forms and methods for using sameDEPOMED INC·Filed 2013·Application pending·0 cites
- 4163US2016206558A1Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesicDEPOMED INC·Filed 2016·Application pending·0 cites
- 4262US2006159743A1Methods of treating non-nociceptive pain states with gastric retentive gabapentinDEPOMED INC·Filed 2005·Application pending·0 cites
- 4361US2017172930A1Shell-and-core dosage form approaching zero-order drug releaseDEPOMED INC·Filed 2017·Application pending·0 cites
- 4456US9814705B2Intranasal spray device containing pharmaceutical compositionDEPOMED INC·Filed 2015·Granted Nov 14, 2017·0 cites·26 claims
- 4555US2013149379A1Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tractDEPOMED INC·Filed 2012·Application pending·0 cites
- 4655US2011218246A1Methods of treating non-nociceptive pain states with gastric retentive gabapentinDEPOMED INC·Filed 2011·Application pending·0 cites
- 4753US2002051820A1Extending the duration of drug release within the stomach during the fed modeDEPOMED INC·Filed 2001·Application pending·0 cites
- 4853US2007184104A1Gastric retentive gabapentin dosage forms and methods for using sameDEPOMED INC·Filed 2006·Application pending·0 cites
- 4953US2013158121A1Methods for treating vasomotor symptoms using gaba analogs in a gastric retentive dosage formDEPOMED INC·Filed 2012·Application pending·0 cites
- 5052US2013316002A1Compositions and methods for treating gastrointestinal motility dysfunctionDEPOMED INC·Filed 2013·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when DEPOMED INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →